These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28727188)

  • 1. MiR-21: A key player in glioblastoma pathogenesis.
    Masoudi MS; Mehrabian E; Mirzaei H
    J Cell Biochem; 2018 Feb; 119(2):1285-1290. PubMed ID: 28727188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma.
    Yin J; Zeng A; Zhang Z; Shi Z; Yan W; You Y
    EBioMedicine; 2019 Apr; 42():238-251. PubMed ID: 30917935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma: exosome and microRNA as novel diagnosis biomarkers.
    Saadatpour L; Fadaee E; Fadaei S; Nassiri Mansour R; Mohammadi M; Mousavi SM; Goodarzi M; Verdi J; Mirzaei H
    Cancer Gene Ther; 2016 Dec; 23(12):415-418. PubMed ID: 27834360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response.
    Besse A; Sana J; Lakomy R; Kren L; Fadrus P; Smrcka M; Hermanova M; Jancalek R; Reguli S; Lipina R; Svoboda M; Slampa P; Slaby O
    Tumour Biol; 2016 Jun; 37(6):7719-27. PubMed ID: 26692101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
    Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
    Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma.
    Alfardus H; McIntyre A; Smith S
    Biomed Res Int; 2017; 2017():9157370. PubMed ID: 28804724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.
    Yang F; Liu X; Liu Y; Liu Y; Zhang C; Wang Z; Jiang T; Wang Y
    Cancer Lett; 2017 Jun; 396():1-9. PubMed ID: 28286260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-Mediated Dynamic Bidirectional Shift between the Subclasses of Glioblastoma Stem-like Cells.
    Rooj AK; Ricklefs F; Mineo M; Nakano I; Chiocca EA; Bronisz A; Godlewski J
    Cell Rep; 2017 Jun; 19(10):2026-2032. PubMed ID: 28591575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal noncoding RNAs: key players in glioblastoma drug resistance.
    Movahedpour A; Khatami SH; Khorsand M; Salehi M; Savardashtaki A; Mirmajidi SH; Negahdari B; Khanjani N; Naeli P; Vakili O; Taheri-Anganeh M
    Mol Cell Biochem; 2021 Nov; 476(11):4081-4092. PubMed ID: 34273059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of PDGFRB and EGFR in microvascular proliferation in glioblastoma.
    Xu G; Li JY
    Tumour Biol; 2016 Aug; 37(8):10577-86. PubMed ID: 26857280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma.
    Yu W; Liang S; Zhang C
    Neuromolecular Med; 2018 Dec; 20(4):452-474. PubMed ID: 30182330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.
    Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH
    OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of miRNA-7 by genome-wide analysis as a critical sensitizer for TRAIL-induced apoptosis in glioblastoma cells.
    Zhang X; Zhang X; Hu S; Zheng M; Zhang J; Zhao J; Zhang X; Yan B; Jia L; Zhao J; Wu K; Yang A; Zhang R
    Nucleic Acids Res; 2017 Jun; 45(10):5930-5944. PubMed ID: 28459998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-210 regulates cell proliferation and apoptosis by targeting regulator of differentiation 1 in glioblastoma cells.
    Zhang S; Lai N; Liao K; Sun J; Lin Y
    Folia Neuropathol; 2015; 53(3):236-44. PubMed ID: 26443314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR‑124‑3p inhibits the viability and motility of glioblastoma multiforme by targeting RhoG.
    Cai S; Shi CJ; Lu JX; Wang YP; Yuan T; Wang XP
    Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33649803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review.
    Ahir BK; Ozer H; Engelhard HH; Lakka SS
    Crit Rev Oncol Hematol; 2017 Dec; 120():22-33. PubMed ID: 29198335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes of glioma cells deliver miR-148a to promote proliferation and metastasis of glioblastoma via targeting CADM1.
    Cai Q; Zhu A; Gong L
    Bull Cancer; 2018; 105(7-8):643-651. PubMed ID: 29921422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA and Exosome in Retinal-related Diseases: Their Roles in the Pathogenesis and Diagnosis.
    Salmaninejad A; Pourali G; Shahini A; Darabi H; Azhdari S
    Comb Chem High Throughput Screen; 2022; 25(2):211-228. PubMed ID: 33390101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated miR-671-5p / CDR1-AS / CDR1 / VSNL1 axis is involved in glioblastoma multiforme.
    Barbagallo D; Condorelli A; Ragusa M; Salito L; Sammito M; Banelli B; Caltabiano R; Barbagallo G; Zappalà A; Battaglia R; Cirnigliaro M; Lanzafame S; Vasquez E; Parenti R; Cicirata F; Di Pietro C; Romani M; Purrello M
    Oncotarget; 2016 Jan; 7(4):4746-59. PubMed ID: 26683098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool.
    Manterola L; Guruceaga E; Gállego Pérez-Larraya J; González-Huarriz M; Jauregui P; Tejada S; Diez-Valle R; Segura V; Samprón N; Barrena C; Ruiz I; Agirre A; Ayuso A; Rodríguez J; González A; Xipell E; Matheu A; López de Munain A; Tuñón T; Zazpe I; García-Foncillas J; Paris S; Delattre JY; Alonso MM
    Neuro Oncol; 2014 Apr; 16(4):520-7. PubMed ID: 24435880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.